Valuation: BioElectronics Corporation

Market Cap 12.35M 11.08M 10.25M 9.28M 17.34M 1.18B 17.55M 123M 48.8M 616M 46.35M 45.38M 1.95B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 23.05M 21.31M 19.3M 36.06M 2.45B 36.5M 255M 101M 1.28B 96.42M 94.39M 4.07B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
3 months-14.29%
6 months-25.00%
Current year-25.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 2019-11-14
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 2020-06-14
Director/Board Member - 2019-11-14
Director/Board Member - 2024-12-02
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-40.00%0.00% 7.41M
+1.61%+1.46%+26.28%+63.22% 260B
+0.89%+0.09%+7.92%+24.58% 165B
-0.38%+3.75%-18.56%+71.51% 154B
-5.84%-4.67%-57.98%-14.32% 61.49B
+1.06%+3.82%+11.67%+48.73% 52.9B
+0.43%+2.54%-13.23%-6.45% 52.84B
+1.39%-0.85%+9.09%+67.70% 51.46B
+2.25%+2.10%+24.43%+76.59% 51.16B
+1.78%+4.24%+37.85%+94.84% 46.85B
Average +0.84%+1.20%-1.25%+42.64% 89.57B
Weighted average by Cap. +0.89%+1.41%+5.73%+49.93%

Financials

2020 2021
Net sales 830K 744K 688K 623K 1.16M 79.01M 1.18M 8.23M 3.28M 41.34M 3.11M 3.05M 131M 1.61M 1.44M 1.34M 1.21M 2.26M 153M 2.29M 15.96M 6.36M 80.21M 6.04M 5.91M 255M
Net income -1.16M -1.04M -962K -871K -1.63M -110M -1.65M -11.5M -4.58M -57.8M -4.35M -4.26M -183M -290K -260K -240K -218K -407K -27.6M -412K -2.87M -1.14M -14.44M -1.09M -1.06M -45.85M
Net Debt 13.07M 11.72M 10.84M 9.82M 18.34M 1.24B 18.56M 130M 51.62M 651M 49.04M 48M 2.07B 13.34M 11.97M 11.07M 10.02M 18.73M 1.27B 18.95M 132M 52.7M 665M 50.07M 49.01M 2.11B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
26-10-28 $0.000300 0.00% 9,174,694
26-10-27 $0.000300 0.00% 343,500
26-10-26 $0.000300 0.00% 379,500
26-10-23 $0.000300 0.00% 5,059,897
26-10-22 $0.000300 0.00% 10,100,000
  1. Stock Market
  2. Stocks
  3. BIEL Stock